LYRACELL Lab: where each treatment becomes a specific preparation.
LYRACELL Lab is the clinic’s in-house laboratory. This is where the cells are processed and the therapies defined by the medical team are prepared, following the protocols of the Moviglia Method.
Integrated into LYRACELL’s clinical practice, the laboratory makes it possible to coordinate cell preparation, quality control and traceability within a single therapeutic process.
In-house laboratoryMoviglia Method20+ years of researchBuenos Aires

The diagnosis guides the medical indication. LYRACELL Lab takes it to the laboratory to develop the corresponding cell preparation.
Before processing begins, the LYRACELL Lab team receives information about the tissue to be treated and the strategy defined for the patient.
From there, the team plans the work stages, prepares the necessary cell populations and coordinates timing with the medical team. This communication continues throughout the entire process.
Each application also requires a work sequence coordinated with the scheduled treatment date. The laboratory begins its work several days in advance, following specific cell activation and processing times.

Which cells are processed at LYRACELL Lab.
LYRACELL Lab has the structural conditions and qualified professional team to process different tissues and cell populations.
Stem cells from perinatal (feto-maternal) tissues: umbilical cord, placenta and amniotic fluid.
Stem cells obtained from bone marrow.
Stem cells obtained from adipose tissue.
Mononuclear cells obtained from peripheral blood.
The process at LYRACELL Lab.
At LYRACELL Lab, the infrastructure and specialized technical team make it possible to carry out the processes needed to prepare the cell populations required for each treatment. These processes include:
- Selection, expansion, differentiation and cryopreservation of stem cells.
- Selection, activation and cryopreservation of specific immune system cell populations.
LYRACELL Lab works under controlled conditions.
As an in-house laboratory, LYRACELL Lab brings the selection, processing and preparation of the cells for each treatment together in one place.
LYRACELL Lab is organized into separate pre-production, production and quality control areas. Structural conditions for isolation, filtration and air pressure help control the environment where the cells are processed.
The production areas operate with ISO 5 air quality, while the pre-production areas operate with ISO 7 air quality. These classifications set levels of airborne particle control and are part of the conditions used to reduce contamination risks during cell processing.

Tracking each preparation from its origin to its application.
Traceability makes it possible to follow the path of the cells at every stage, from collection to application, identify the origin of each preparation and keep a record of the entire process.
Quality control
In cell therapy, the preparations administered contain living cells, so every stage of the process requires rigorous controls. Quality control makes it possible to verify that the cells are viable, that they retain their characteristics and that there is no contamination, as part of the quality and safety conditions of the process. In addition, standardizing and recording each procedure makes it possible to maintain quality and consistency criteria over time.
Cryopreservation
Cell cryopreservation is a process that preserves cells at very low temperatures, usually in liquid nitrogen, to reduce their metabolic activity and allow them to be stored. In this way they can be kept for years and, after thawing, their viability and characteristics are evaluated before use.
Stem cells and non-activated immune system cells can be cryopreserved and used according to the patient’s needs.
Cryopreservation can make it possible to preserve cells obtained in a single collection for use at different stages of treatment, according to the corresponding protocol.
Everything you need to know about LYRACELL Lab
It is LYRACELL’s in-house laboratory, dedicated to processing and preparing the cells used in each treatment according to the protocols of the Moviglia Method.
The cells are identified, separated, processed and quantified according to the tissue defined in the treatment proposal. Quality controls are also performed before they are released.
LYRACELL Lab is organized into separate pre-production, production and quality control areas, with ISO 5 air quality in production and ISO 7 in pre-production, and it records the traceability of each preparation.
They are classifications related to air quality and particle control in environments where processes requiring controlled conditions are carried out. LYRACELL Lab works with ISO 5 air quality in production and ISO 7 in pre-production.
LYRACELL Lab can process stem cells from different tissues as well as immune system cells. Their origin and preparation are defined according to the corresponding protocol and each patient’s medical indication.
No. LYRACELL Lab does not modify the genome of the cells.
No. Each application requires prior preparation. The laboratory begins working several days in advance and coordinates cell activation and preparation times with the scheduled treatment date.
Yes. The protocol includes serological tests of the patient before and after treatment.
Yes. Certain cell populations can be cryopreserved to keep them available for the following stages of the protocol, according to the corresponding indication.
Every therapy begins long before its application.
Learn how LYRACELL Lab turns a medical indication into a specific cell preparation.